Characterization of the human plasma phosphoproteome using linear ion trap mass spectrometry and multiple search engines

Journal of Proteome Research

Volumn 9, Issue 2, 2010, Pages 876-884

  Carrascal, Montserrat ^a   Gay, Marina ^a   Ovelleiro, David ^a   Casas, Vanessa ^a   Gelpí, Emilio ^a   Abian, Joaquin ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

Biomarkers; Combined search engines; Human plasma; Phosphopeptide purification; Phosphoproteomics

Indexed keywords

PHOSPHOPROTEIN; PLASMA PROTEIN; PROTEOME;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; ENZYME ACTIVITY; ENZYME REGULATION; GENE MAPPING; HUMAN; INTERMETHOD COMPARISON; ION TRAP MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SEARCH ENGINE; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 76149133112     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900780s     Document Type: Article

References (47)

1. Geoerger, B.; Gaspar, N.; Opolon, P.; Morizet, J.; Devanz, P.; Lecluse, Y.; Valent, A.; Lacroix, L.; Grill, J.; Vassal, G. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts. Int. J. Cancer 2008, 123 (1), 209-216.
2. Yamada, M.; Ikeda, Y.; Yano, M.; Yoshimura, K.; Nishino, S.; Aoyama, H.; Wang, L.; Aoki, H.; Matsuzaki, M. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy. FASEB J. 2006, 20 (8), 1197-1199.
3. Olsen, J. V.; Blagoev, B.; Gnad, F.; Macek, B.; Kumar, C.; Mortensen, P.; Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127, 635-648.
4. Zanivan, S.; Gnad, F.; Wickstrom, S. A.; Geiger, T.; Macek, B.; Cox, J.; Fassler, R.; Mann, M. Solid Tumor Proteome and Phosphoproteome Analysis by High Resolution Mass Spectrometry. J. Proteome Res. 2008, 7, 5314-5326.
5. Bakalarski, C. E.; Haas, W.; Dephoure, N. E.; Gygi, S. P. The effects of mass accuracy, data acquisition speed, and search algorithm choice on peptide identification rates in phosphoproteomics. Anal. Bioanal. Chem. 2007, 389, 1409-1419.
6. Domon, B.; Bodenmiller, B.; Carapito, C.; Hao, Z.; Huehmer, A.; Aebersold, R. Electron Transfer Dissociation in Conjunction with Collision Activation To Investigate the Drosophila melanogaster Phosphoproteome. J. Proteome Res. 2009, 8, 2633-2639.
7. Mann, M.; Kelleher, N. L. Precision proteomics: high mass accuracy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (47), 18132-18138.
8. Bahl, J. M. C.; Jensen, S. S.; Larser, M. R.; Heegaard, N. H. H. Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry. Anal. Chem. 2008, 80, 6308-6316.
9. Cirulli, C.; Chiappetta, G.; Marino, G.; Mauri, P.; Amoresano, A. Identification of free phosphopeptides in different biological fluids by a mass spectrometry approach. Anal. Bioanal. Chem. 2008, 392, 147-159.
10. Hu, L.; Zhou, H.; Li, Y.; Sun, S.; Guo, L.; Ye, M.; Tian, X.; Gu, J.; Yang, S.; Zou, H. Profiling of Endogenous Serum Phosphorylated Peptides by Titanium (IV) Immobilized Mesoporous Silica Particles Enrichment and MALDI-TOFMS Detection. Anal. Chem. 2009, 81 (1), 94-104.
11. Li, Y.; Qi, D.; Deng, C.; Yang, P.; Zhang, X. Cerium Ion-Chelated Magnetic Silica Microspheres for Enrichment and Direct Determination of Phosphopeptides by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry. J. Proteome Res. 2008, 7 (4), 1767-1777.
12. Gonzales, P. A.; Pisitkun, T.; Hoffert, J. D.; Tchapyjnikov, D.; Star, R. A.; Kleta, R.; Wang, N. S.; Knepper, M. A. Large-Scale Proteomics and Phosphoproteomics of Urinary Exosomes. J. Am. Soc. Nephrol. 2009; doi: 10.1681/ASN.2008040406.
13. Anderson, N. L.; Anderson, N. G. The Human Plasma Proteome. History, character, and diagnostic prospects. Mol. Cell Proteomics 2002, 1, 845-867.
14. Turner, M. W.; Hulme, B. The Plasma Proteins: An Introduction; Pitman Medical & Scientific Publishing Co., Ltd.: London, 1970.
15. Pan, S.; Zhu, D.; Quinn, J. F.; Peskind, E. R.; Montine, T. J.; Lin, B.; Goodlett, D. R.; Taylor, G.; Eng, J.; Zhang, J. A combined dataset of human cerebrospinal fluid proteins identified by multidimensional chromatography and tandem mass spectrometry. Proteomics 2007, 7, 469-473.
16. Adkins, J. N.; Varnum, S. M.; K.J., A.; Moore, R. J.; Angell, N. H.; Smith, R. D.; Springer, D. L.; Pounds, J. L. Toward a Human Blood Serum Proteome: Analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 2002, 4, 7-955.
17. Linke, T.; Doraiswamya, A.; Harrison, E. H. Rat plasma proteomics: Effects of abundant protein depletion on proteomic analysis. J. Chromatogr. 2007, 849, 273-281.
18. Roche, S.; Tiersb, L.; Provansalb, M.; Sevenod, M.; Pivaa, M.-T.; Jouind, P.; Lehmanna, S. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J. Proteomics 2009; doi:10.1016/j.jprot.2009.03.008.
19. Gundry, R. L.; Cotter, R. J. The Albuminome as a Tool for Biomarker Discovery. In Clinical Proteomics. From Diagnosis to Therapy; Van Eyk, J., Dunn, M. J., Eds.; Wiley: London, 2007; pp 263-278.
20. Gay, M.; Carrascal, M.; Gorga, M.; Parés, A.; Abian, J. Characterization of peptides and proteins in commercial human serum albumin solutions Proteomics 2009, DOI: 10.1002/pmic.200900182.
21. Carrascal, M.; Ovelleiro, D.; Casas, V.; Gay, M.; Abian, J. Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment. J. Proteome Res. 2008, 7, 5167-5176.
22. Eng, J. K.; McCormack, A. L.; Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989.
23. Geer, L. Y.; Markey, S. P.; Kowalak, J. A.; Wagner, L.; Xu, M.; Maynard, D. M.; Yang, X.; Shi, W.; Bryant, S. H. Open mass spectrometry search algorithm. J. Proteome Res. 2004, 3 (5), 958-964.
24. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
25. Beausoleil, S. A.; Villen, J.; Gerber, S. A.; Rush, J.; Gysi, S. P. A probability-based approach for high-throughtput protein phosphorylation analysis and site localization. Nat. Biotechnol. 2006, 24 (10), 1285-1292.
26. Ovelleiro, D.; Carrascal, M.; Casas, V.; Abian, J. LymPHOS: Design of a phosphosite database of primary human T cells. Proteomics 2009, 9, 3741-3751.
27. Thingholm, T. E.; Jensen, O. N.; Robinson, P. J.; Larsen, M. R. SIMAC - A phosphoproteomic strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptide. Mol. Syst. Biol. 2008, 7, 661-671.
28. Pan, C.; Olsen, J.; Daub, H.; Mann, M. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol. Cell. Proteomics 2009, 8, 2796-2808.
29. Balgley, B. M.; Laudeman, T.; Yang, L.; Song, T.; Le, C. S. Comparative Evaluation of Tandem MS Search Algorithms Using a Target-Decoy Search Strategy. Mol. Cell. Proteomics 2007, 6, 1599-1608.
30. Jones, A. R.; Siepen, J. A.; Hubbard, S. J.; Paton, N. W. Improving sensitivity in proteome studies by analysis of false discovery rates for multiple search engines. Proteomics 2009, 9, 1220-1229.
31. Searle, B. C.; Turner, M.; Nesvizhskii, A. I. Improving Sensitivity by Probabilistically Combining Resuts from Multiple MS/MS Search Methodologies. J. Proteome Res. 2008, 7, 245-253.
32. Larsen, M. R.; Thingholm, T. E.; Jensen, O. N.; Roepstorff, P.; Jørgensen, T. J. D. Highly Selective Enrichment of Phosphorylated Peptides from Peptide Mixtures Using Titanium Dioxide Microcolumns. Mol. Cell. Proteomics 2006, 4, 873-876.
33. Gilar, M.; Ying-Qing, Y.; Ahn, J.; Fournier, J.; Gebler, J. C. Mixedmode chromatography for fractionation of peptides, phosphopeptides, and sialylated glycopeptides. J. Chromatogr., A 2008, 1191, 162-170.
34. Schwartz, D.; Gysi, S. P. An iterative stadistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 2005, 23 (11), 1391-1398.
35. Amanchy, R.; Periaswamy, B.; Mathivanan, S.; Reddy, R.; Tattikota, S. G.; Pandey, A. A curated compedium of phosphorylation motifs. Nat. Biotechnol. 2007, 25 (3), 285-286.
36. Yocum, A.; Yu, K.; Oe, T.; Blair, I. Effect of immunoaffinity depletion of human serum during proteomic investigations. J. Proteome Res. 2005, 4 (5), 1722-1731.
37. Liu, T.; Qian, W. J.; Mottaz, H. M.; Gritsenko, M. A.; Norbeck, A. D.; Moore, R. J.; Purvine, S. O.; Camp II, D. G.; Smith, R. D. Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry. Mol. Cell. Proteomics 2006, 5, 2167-2174.
38. Waisman, D. Plasminogen. Structure, Activation, and Regulation; Kluwer Academic/Plenum Publishers: New York, 2000.
39. McMahon, B.; Kwaan, H. The Plasminogen Activator System and Cancer. Pathophysiol. Haemost. Thromb. 2007, 8 (36), 184-194.
40. Kwaan, H. C.; McMahon, B. The role of plasminogen-plasmin system in cancer. Cancer Treat Res. 2009, 148, 43-66.
41. Zorio, E.; Gilabert-Estellés, J.; España, F.; Ramón, L.; Cosín, R.; Estellés, A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr. Med. Chem. 2008, 15 (9), 923-929.
42. Shariat, S.; Roehrborn, C.; McConnell, J.; Park, S.; Alam, N.; Wheeler, T.; Slawin, K. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J. Clin. Oncol. 2007, 25 (4), 349-355.
43. Wang, H.; Prorok, M.; Bretthauer, R. K.; Castellino, F. J. Serine-578 Is a Major Phosphorylation Locus in Human Plasma Plasminogen. Biochemistry 1997, 36, 8100-8106.
44. Castellino, F. J.; Ploplis, V. A. Human Plasminogen: Structure, Activation and Function. In Plasminogen. Structure, Activation, and Regulation; Waisman, D. M., Ed.; Klewer Academic/Plenum Publishers: New York, 2000; pp 3-11.
45. Franco, P.; Iaccarino, C.; Chiaradonna, F.; Brandazza, A.; Iavarone, D.; Mastronicola, M.; Nolli, M.; Stoppelli, M. Phosphorylation of Human Pro-Urokinase on Ser138/303 Impairs Its Receptor-dependent Ability to Promote Myelomonocytic Adherence and Motility. J. Cell Biol. 1997, 137 (3), 779-791.
46. Barlati, S.; De Petro, G.; Bona, C.; Paracini, F.; Tonelli, M. Phosphorylation of human plasminogen activators and plasminogen. FEBS Lett. 1995, 363, 170-174.
47. Mancone, C.; Amicone, L.; Fimia, G.; Bravo, E.; Piacentini, M.; Tripodi, M.; Alonzi, T. Proteomic analysis of human very lowdensity lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics 2007, 7, 143-154.